Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure.

Bushnell DM, McCarrier KP, Bush EN, Abraham L, Jamieson C, McDougall F, Trivedi MH, Thase ME, Carpenter L, Coons SJ; PRO Consortium's Depression Working Group.

Value Health. 2019 Aug;22(8):906-915. doi: 10.1016/j.jval.2019.02.010. Epub 2019 May 17.

2.

NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.

Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR.

J Nucl Med. 2019 Jul;60(7):937-943. doi: 10.2967/jnumed.118.230607.

PMID:
31263080
3.

Von Hippel-Lindau Acts as a Metabolic Switch Controlling Nephron Progenitor Differentiation.

Cargill K, Hemker SL, Clugston A, Murali A, Mukherjee E, Liu J, Bushnell D, Bodnar AJ, Saifudeen Z, Ho J, Bates CM, Kostka D, Goetzman ES, Sims-Lucas S.

J Am Soc Nephrol. 2019 Jul;30(7):1192-1205. doi: 10.1681/ASN.2018111170. Epub 2019 May 29.

PMID:
31142573
4.

The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy.

Jacobson TA, Cheeley MK, Jones PH, La Forge R, Maki KC, López JAG, Xiang P, Bushnell DM, Martin ML, Cohen JD.

J Clin Lipidol. 2019 May - Jun;13(3):415-424. doi: 10.1016/j.jacl.2019.04.011. Epub 2019 May 18.

PMID:
31113745
5.

Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I).

Bushnell DM, Blum SI, Liedgens H, Martin ML, Freynhagen R, Wallace M, Argoff C, Eerdekens M, Kok M, Patrick DL.

Pain. 2018 Oct;159(10):2066-2075. doi: 10.1097/j.pain.0000000000001309.

6.

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial.

Strosberg J, Wolin E, Chasen B, Kulke M, Bushnell D, Caplin M, Baum RP, Kunz P, Hobday T, Hendifar A, Oberg K, Sierra ML, Thevenet T, Margalet I, Ruszniewski P, Krenning E; NETTER-1 Study Group.

J Clin Oncol. 2018 Sep 1;36(25):2578-2584. doi: 10.1200/JCO.2018.78.5865. Epub 2018 Jun 7.

7.

Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD).

Brod M, Beck JF, Højbjerre L, Bushnell DM, Adalsteinsson JE, Wilkinson L, Rasmussen MH.

Pharmacoecon Open. 2019 Mar;3(1):71-80. doi: 10.1007/s41669-018-0082-3.

8.

90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.

Menda Y, Madsen MT, O'Dorisio TM, Sunderland JJ, Watkins GL, Dillon JS, Mott SL, Schultz MK, Zamba GKD, Bushnell DL, O'Dorisio MS.

J Nucl Med. 2018 Nov;59(11):1692-1698. doi: 10.2967/jnumed.117.202903. Epub 2018 Mar 9.

9.

Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 1-the Patient Assessment for Low Back Pain - Symptoms (PAL-S).

Martin ML, Blum SI, Liedgens H, Bushnell DM, McCarrier KP, Hatley NV, Ramasamy A, Freynhagen R, Wallace M, Argoff C, Eerdekens M, Kok M, Patrick DL.

Pain. 2018 Jun;159(6):1045-1055. doi: 10.1097/j.pain.0000000000001187.

10.

Initial psychometric validation of the questionnaire on pain caused by spasticity (QPS).

Geister TL, Bushnell DM, Yang J, Zhang Y, Martin ML, Heilbronn A, Liu Z.

Health Qual Life Outcomes. 2017 Nov 28;15(1):229. doi: 10.1186/s12955-017-0804-8.

11.

Loss of peri-Wolffian duct stromal Frs2α expression in mice leads to abnormal ureteric bud induction and vesicoureteral reflux.

Narla D, Slagle SB, Schaefer CM, Bushnell DS, Puri P, Bates CM.

Pediatr Res. 2017 Dec;82(6):1022-1029. doi: 10.1038/pr.2017.175. Epub 2017 Aug 9.

12.

Ectopic Phosphorylated Creb Marks Dedifferentiated Proximal Tubules in Cystic Kidney Disease.

Puri P, Schaefer CM, Bushnell D, Taglienti ME, Kreidberg JA, Yoder BK, Bates CM.

Am J Pathol. 2018 Jan;188(1):84-94. doi: 10.1016/j.ajpath.2017.09.015. Epub 2017 Oct 26.

13.

Corrigendum: Double-flow focused liquid injector for efficient serial femtosecond crystallography.

Oberthuer D, Knoška J, Wiedorn MO, Beyerlein KR, Bushnell DA, Kovaleva EG, Heymann M, Gumprecht L, Kirian RA, Barty A, Mariani V, Tolstikova A, Adriano L, Awel S, Barthelmess M, Dörner K, Xavier PL, Yefanov O, James DR, Nelson G, Wang D, Calvey G, Chen Y, Schmidt A, Szczepek M, Frielingsdorf S, Lenz O, Snell E, Robinson PJ, Šarler B, Belšak G, Maček M, Wilde F, Aquila A, Boutet S, Liang M, Hunter MS, Scheerer P, Lipscomb JD, Weierstall U, Kornberg RD, Spence JCH, Pollack L, Chapman HN, Bajt S.

Sci Rep. 2017 Jun 21;7:46846. doi: 10.1038/srep46846.

14.

Endothelial marker-expressing stromal cells are critical for kidney formation.

Mukherjee E, Maringer K, Papke E, Bushnell D, Schaefer C, Kramann R, Ho J, Humphreys BD, Bates C, Sims-Lucas S.

Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F611-F620. doi: 10.1152/ajprenal.00136.2017. Epub 2017 May 24.

15.

The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands.

Hilton HG, McMurtrey CP, Han AS, Djaoud Z, Guethlein LA, Blokhuis JH, Pugh JL, Goyos A, Horowitz A, Buchli R, Jackson KW, Bardet W, Bushnell DA, Robinson PJ, Mendoza JL, Birnbaum ME, Nielsen M, Garcia KC, Hildebrand WH, Parham P.

Cell Rep. 2017 May 16;19(7):1394-1405. doi: 10.1016/j.celrep.2017.04.059.

16.

Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back Pain.

Ramasamy A, Martin ML, Blum SI, Liedgens H, Argoff C, Freynhagen R, Wallace M, McCarrier KP, Bushnell DM, Hatley NV, Patrick DL.

Pain Med. 2017 Jun 1;18(6):1098-1110. doi: 10.1093/pm/pnw357. Review.

PMID:
28340111
17.

Double-flow focused liquid injector for efficient serial femtosecond crystallography.

Oberthuer D, Knoška J, Wiedorn MO, Beyerlein KR, Bushnell DA, Kovaleva EG, Heymann M, Gumprecht L, Kirian RA, Barty A, Mariani V, Tolstikova A, Adriano L, Awel S, Barthelmess M, Dörner K, Xavier PL, Yefanov O, James DR, Nelson G, Wang D, Calvey G, Chen Y, Schmidt A, Szczepek M, Frielingsdorf S, Lenz O, Snell E, Robinson PJ, Šarler B, Belšak G, Maček M, Wilde F, Aquila A, Boutet S, Liang M, Hunter MS, Scheerer P, Lipscomb JD, Weierstall U, Kornberg RD, Spence JC, Pollack L, Chapman HN, Bajt S.

Sci Rep. 2017 Mar 16;7:44628. doi: 10.1038/srep44628. Erratum in: Sci Rep. 2017 Jun 21;7:46846.

18.

Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.

Menda Y, O'Dorisio TM, Howe JR, Schultz M, Dillon JS, Dick D, Watkins GL, Ginader T, Bushnell DL, Sunderland JJ, Zamba GKD, Graham M, O'Dorisio MS.

J Nucl Med. 2017 Jul;58(7):1054-1057. doi: 10.2967/jnumed.116.180984. Epub 2017 Feb 2.

19.

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators.

N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.

20.

Fgfr2 is integral for bladder mesenchyme patterning and function.

Ikeda Y, Zabbarova I, Schaefer CM, Bushnell D, De Groat WC, Kanai A, Bates CM.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F607-F618. doi: 10.1152/ajprenal.00463.2016. Epub 2017 Jan 4.

21.

Six2creFrs2α knockout mice are a novel model of renal cystogenesis.

Puri P, Bushnell D, Schaefer CM, Bates CM.

Sci Rep. 2016 Nov 17;6:36736. doi: 10.1038/srep36736.

22.

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.

Sharma N, Naraev BG, Engelman EG, Zimmerman MB, Bushnell DL Jr, OʼDorisio TM, OʼDorisio MS, Menda Y, Müller-Brand J, Howe JR, Halfdanarson TR.

Pancreas. 2017 Feb;46(2):151-156. doi: 10.1097/MPA.0000000000000734.

23.

Structure of a Complete Mediator-RNA Polymerase II Pre-Initiation Complex.

Robinson PJ, Trnka MJ, Bushnell DA, Davis RE, Mattei PJ, Burlingame AL, Kornberg RD.

Cell. 2016 Sep 8;166(6):1411-1422.e16. doi: 10.1016/j.cell.2016.08.050.

24.

Ablation of the epithelial-specific splicing factor Esrp1 results in ureteric branching defects and reduced nephron number.

Bebee TW, Sims-Lucas S, Park JW, Bushnell D, Cieply B, Xing Y, Bates CM, Carstens RP.

Dev Dyn. 2016 Oct;245(10):991-1000. doi: 10.1002/dvdy.24431. Epub 2016 Jul 28.

25.

Prorenin receptor is critical for nephron progenitors.

Song R, Preston G, Kidd L, Bushnell D, Sims-Lucas S, Bates CM, Yosypiv IV.

Dev Biol. 2016 Jan 15;409(2):382-91. doi: 10.1016/j.ydbio.2015.11.024. Epub 2015 Dec 3.

26.

Structure of an RNA polymerase II preinitiation complex.

Murakami K, Tsai KL, Kalisman N, Bushnell DA, Asturias FJ, Kornberg RD.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13543-8. doi: 10.1073/pnas.1518255112. Epub 2015 Oct 19.

27.

Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.

Feldman SR, Bushnell DM, Klekotka PA, Scanlon M, Martin ML, Wade SW, Yang W, Pinto L, Kircik L, Viswanathan HN.

J Dermatolog Treat. 2016;27(3):224-7. doi: 10.3109/09546634.2015.1093589. Epub 2015 Oct 7.

PMID:
26447179
28.

Molecular architecture of the yeast Mediator complex.

Robinson PJ, Trnka MJ, Pellarin R, Greenberg CH, Bushnell DA, Davis R, Burlingame AL, Sali A, Kornberg RD.

Elife. 2015 Sep 24;4. pii: e08719. doi: 10.7554/eLife.08719.

29.

Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.

Hilton HG, Guethlein LA, Goyos A, Nemat-Gorgani N, Bushnell DA, Norman PJ, Parham P.

J Immunol. 2015 Oct 1;195(7):3160-70. doi: 10.4049/jimmunol.1501358. Epub 2015 Aug 26.

30.

Deconvolution method for specific and nonspecific binding of ligand to multiprotein complex by native mass spectrometry.

Guan S, Trnka MJ, Bushnell DA, Robinson PJ, Gestwicki JE, Burlingame AL.

Anal Chem. 2015 Aug 18;87(16):8541-6. doi: 10.1021/acs.analchem.5b02258. Epub 2015 Jul 29.

31.

Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors.

Bushnell DL, Madsen MT, O'cdorisio T, Menda Y, Muzahir S, Ryan R, O'dorisio MS.

EJNMMI Res. 2014 Dec;4(1):38. doi: 10.1186/s13550-014-0038-2. Epub 2014 Sep 10.

32.

Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO).

Brod M, Højbjerre L, Bushnell DM, Hansen CT.

Qual Life Res. 2015 Dec;24(12):2971-84. doi: 10.1007/s11136-015-1023-6. Epub 2015 Jun 21.

PMID:
26094008
33.

Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.

Brod M, Blum SI, Bushnell DM, Ramasamy A.

Qual Life Res. 2015 Dec;24(12):3001-14. doi: 10.1007/s11136-015-1037-0. Epub 2015 Jun 12.

PMID:
26068732
34.

The experience of pain and redness in patients with moderate to severe plaque psoriasis.

Martin ML, Gordon K, Pinto L, Bushnell DM, Chau D, Viswanathan HN.

J Dermatolog Treat. 2015 Oct;26(5):401-5. doi: 10.3109/09546634.2014.996514. Epub 2015 Sep 4.

35.

Fgfr2 is integral for bladder mesenchyme patterning and function.

Walker KA, Ikeda Y, Zabbarova I, Schaefer CM, Bushnell D, De Groat WC, Kanai A, Bates CM.

Am J Physiol Renal Physiol. 2015 Apr 15;308(8):F888-98. doi: 10.1152/ajprenal.00624.2014. Epub 2015 Feb 4. Retraction in: Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F239.

36.

Fibroblast growth factor receptor-Frs2α signaling is critical for nephron progenitors.

Di Giovanni V, Walker KA, Bushnell D, Schaefer C, Sims-Lucas S, Puri P, Bates CM.

Dev Biol. 2015 Apr 1;400(1):82-93. doi: 10.1016/j.ydbio.2015.01.018. Epub 2015 Jan 30.

37.

The Pain Assessment for Lower Back Symptoms (Pal-S): Refinement of A New Pro Instrument Through A Mixed Methods Approach.

McCarrier KP, Bushnell DM, Ramasamy A, Liedgens H, Blum SI, Cano S, Martin ML, Patrick DL.

Value Health. 2014 Nov;17(7):A536. doi: 10.1016/j.jval.2014.08.1712. Epub 2014 Oct 26. No abstract available.

38.

Impacts of Lower Back Pain: Refinement of the Pain Assessment for Lower Back-Impacts Questionnaire (Pal-I) Using a Mixed Methods Approach.

Bushnell DM, McCarrier KP, Ramasamy A, Liedgens H, Blum SI, Cano S, Martin ML, Patrick DL.

Value Health. 2014 Nov;17(7):A536. doi: 10.1016/j.jval.2014.08.1713. Epub 2014 Oct 26. No abstract available.

39.

Nanoparticle imaging. Electron microscopy of gold nanoparticles at atomic resolution.

Azubel M, Koivisto J, Malola S, Bushnell D, Hura GL, Koh AL, Tsunoyama H, Tsukuda T, Pettersson M, Häkkinen H, Kornberg RD.

Science. 2014 Aug 22;345(6199):909-12. doi: 10.1126/science.1251959.

40.

Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection.

Campfield BT, Nolder CL, Marinov A, Bushnell D, Davis A, Spychala C, Hirsch R, Nowalk AJ.

Microb Pathog. 2014 Aug;73:70-9. doi: 10.1016/j.micpath.2014.04.005. Epub 2014 Apr 24.

41.

Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells.

Chaly Y, Blair HC, Smith SM, Bushnell DS, Marinov AD, Campfield BT, Hirsch R.

Ann Rheum Dis. 2015 Jul;74(7):1467-73. doi: 10.1136/annrheumdis-2013-204822. Epub 2014 Mar 18.

PMID:
24641944
42.

Ablation of the renal stroma defines its critical role in nephron progenitor and vasculature patterning.

Hum S, Rymer C, Schaefer C, Bushnell D, Sims-Lucas S.

PLoS One. 2014 Feb 5;9(2):e88400. doi: 10.1371/journal.pone.0088400. eCollection 2014.

43.

Dicer function is required in the metanephric mesenchyme for early kidney development.

Chu JY, Sims-Lucas S, Bushnell DS, Bodnar AJ, Kreidberg JA, Ho J.

Am J Physiol Renal Physiol. 2014 Apr 1;306(7):F764-72. doi: 10.1152/ajprenal.00426.2013. Epub 2014 Feb 5.

44.

Follistatin-like protein 1 enhances NLRP3 inflammasome-mediated IL-1β secretion from monocytes and macrophages.

Chaly Y, Fu Y, Marinov A, Hostager B, Yan W, Campfield B, Kellum JA, Bushnell D, Wang Y, Vockley J, Hirsch R.

Eur J Immunol. 2014 May;44(5):1467-79. doi: 10.1002/eji.201344063. Epub 2014 Feb 20.

45.

Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization.

Brod M, Wolden M, Christensen T, Bushnell DM.

Value Health. 2013 Dec;16(8):1140-9. doi: 10.1016/j.jval.2013.09.002. Epub 2013 Oct 30.

46.

Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2.

Brod M, Wolden M, Groleau D, Bushnell DM.

J Med Econ. 2014 Jan;17(1):11-20. doi: 10.3111/13696998.2013.857676. Epub 2013 Nov 12.

PMID:
24199622
47.

Architecture of an RNA polymerase II transcription pre-initiation complex.

Murakami K, Elmlund H, Kalisman N, Bushnell DA, Adams CM, Azubel M, Elmlund D, Levi-Kalisman Y, Liu X, Gibbons BJ, Levitt M, Kornberg RD.

Science. 2013 Nov 8;342(6159):1238724. doi: 10.1126/science.1238724. Epub 2013 Sep 26.

48.

Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory.

Bushnell DM, Martin ML, Scanlon M, Chen T, Chau D, Viswanathan HN.

Qual Life Res. 2014 Apr;23(3):897-906. doi: 10.1007/s11136-013-0527-1. Epub 2013 Sep 20.

PMID:
24052326
49.

Endothelial Progenitors Exist within the Kidney and Lung Mesenchyme.

Sims-Lucas S, Schaefer C, Bushnell D, Ho J, Logar A, Prochownik E, Gittes G, Bates CM.

PLoS One. 2013 Jun 18;8(6):e65993. doi: 10.1371/journal.pone.0065993. Print 2013.

50.

AutoDrug: fully automated macromolecular crystallography workflows for fragment-based drug discovery.

Tsai Y, McPhillips SE, González A, McPhillips TM, Zinn D, Cohen AE, Feese MD, Bushnell D, Tiefenbrunn T, Stout CD, Ludaescher B, Hedman B, Hodgson KO, Soltis SM.

Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):796-803. doi: 10.1107/S0907444913001984. Epub 2013 Apr 11.

Supplemental Content

Loading ...
Support Center